Copeland Capital Management LLC Sells 47,975 Shares of The Ensign Group, Inc. $ENSG

Copeland Capital Management LLC decreased its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.5% in the first quarter, Holdings Channel reports. The institutional investor owned 593,425 shares of the company’s stock after selling 47,975 shares during the period. The Ensign Group accounts for about 2.7% of Copeland Capital Management LLC’s portfolio, making the stock its largest position. Copeland Capital Management LLC’s holdings in The Ensign Group were worth $119,575,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in The Ensign Group by 9.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. raised its stake in shares of The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock worth $50,000 after buying an additional 230 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of The Ensign Group by 65.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi increased its holdings in The Ensign Group by 480,216.7% in the 2nd quarter. Amundi now owns 57,638 shares of the company’s stock worth $8,583,000 after acquiring an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in The Ensign Group by 26.1% in the 2nd quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock worth $314,000 after acquiring an additional 421 shares in the last quarter. 96.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ENSG has been the topic of several research analyst reports. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Truist Financial lowered their price objective on The Ensign Group from $215.00 to $202.00 and set a “hold” rating on the stock in a report on Tuesday. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Finally, Zacks Research downgraded The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, The Ensign Group has an average rating of “Moderate Buy” and a consensus price target of $213.50.

The Ensign Group Stock Performance

NASDAQ:ENSG opened at $171.28 on Friday. The company’s 50-day moving average is $165.85 and its two-hundred day moving average is $184.01. The firm has a market capitalization of $10.01 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 1.69 and a beta of 0.69. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.56 and a quick ratio of 1.56. The Ensign Group, Inc. has a 1-year low of $134.79 and a 1-year high of $218.00.

The Ensign Group (NASDAQ:ENSG) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The firm had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Analysts forecast that The Ensign Group, Inc. will post 6.82 EPS for the current year.

The Ensign Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is presently 4.23%.

Insider Activity

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director directly owned 9,295 shares in the company, valued at $1,858,721.15. This trade represents a 4.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,792 shares of company stock worth $320,931. 4.00% of the stock is owned by insiders.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.